Rampart Biosciences

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive
Tue, 10/24/23 - 09:59 am
Rampart Biosciences
OrbiMed
Alexion Pharmaceuticals
Strensiq
hypophosphatasia